Thomas D. Schiano
#165,528
Most Influential Person Now
Thomas D. Schiano's AcademicInfluence.com Rankings
Thomas D. Schianophilosophy Degrees
Philosophy
#9726
World Rank
#13328
Historical Rank
Logic
#6689
World Rank
#8234
Historical Rank
Thomas D. Schianobiology Degrees
Biology
#13391
World Rank
#16936
Historical Rank
Virology
#332
World Rank
#339
Historical Rank
Biochemistry
#2342
World Rank
#2491
Historical Rank
Download Badge
Philosophy Biology
Thomas D. Schiano's Degrees
- PhD Biochemistry University of California, Berkeley
- Doctorate Medicine Stanford University
Why Is Thomas D. Schiano Influential?
(Suggest an Edit or Addition)Thomas D. Schiano's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis. (2015) (694)
- Evidence-based incorporation of serum sodium concentration into MELD. (2006) (638)
- Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study. (2015) (336)
- 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody‐Mediated Rejection (2016) (330)
- One Hundred Nine Living Donor Liver Transplants in Adults and Children: A Single-Center Experience (2001) (313)
- Review article: drug hepatotoxicity (2007) (245)
- Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites (2006) (206)
- Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection (2012) (198)
- Adult Living Donor Liver Transplantation for Patients With Hepatocellular Carcinoma: Extending UNOS Priority Criteria (2004) (192)
- Early Liver Transplantation for Severe Alcoholic Hepatitis in the United States—A Single‐Center Experience (2016) (183)
- Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease (2000) (174)
- A randomized, open‐label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients (2005) (173)
- Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. (2007) (160)
- The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome. (2009) (157)
- Early and late outcome of cardiac surgery in patients with liver cirrhosis (2007) (150)
- Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. (1996) (137)
- Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol‐Associated Liver Disease (2020) (130)
- Monoclonal antibody HCV‐AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study (2006) (128)
- Quality of life after lobectomy for adult liver transplantation. (2002) (127)
- Isolated intestinal transplantation: proof of clinical efficacy (2003) (122)
- Accuracy and significance of computed tomographic scan assessment of hepatic volume in patients undergoing liver transplantation. (2000) (119)
- Randomised clinical study: GR‐MD‐02, a galectin‐3 inhibitor, vs. placebo in patients having non‐alcoholic steatohepatitis with advanced fibrosis (2016) (118)
- Factors that predict outcome of abdominal operations in patients with advanced cirrhosis. (2010) (116)
- Intestinal transplantation before and after the introduction of sirolimus1 (2002) (115)
- Hepatoportal Sclerosis as a Cause of Noncirrhotic Portal Hypertension in Patients With HIV (2007) (114)
- Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up‐to‐seven criteria (2009) (108)
- Mortality associated with carbapenem‐resistant Klebsiella pneumoniae infections in liver transplant recipients (2012) (107)
- Clinical course and management of inflammatory bowel disease after liver transplantation. (1998) (105)
- Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. (2012) (104)
- Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus (2008) (103)
- Adult living donor liver transplantation: The hepatologist's perspective (2001) (99)
- Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C. (2005) (97)
- Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts (2006) (95)
- Outcome analysis of cirrhotic patients undergoing chest tube placement. (2004) (90)
- Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation (2013) (87)
- Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. (1998) (87)
- Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients (2014) (86)
- Human Monoclonal Antibody MBL‐HCV1 Delays HCV Viral Rebound Following Liver Transplantation: A Randomized Controlled Study (2013) (85)
- Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction (2002) (83)
- Results of retransplantation for recurrent hepatitis C (2003) (81)
- Rapidly progressive liver injury and fatal alcoholic hepatitis occurring after liver transplantation in alcoholic patients. (1999) (79)
- COVID-19 in Liver Transplant Recipients: An Initial Experience From the US Epicenter (2020) (77)
- Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second‐line Therapy for Patients With Autoimmune Hepatitis (2017) (76)
- Acute liver failure caused by 'fat burners' and dietary supplements: a case report and literature review. (2011) (76)
- A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis (2020) (72)
- Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. (2014) (69)
- The Variable Pathology of Kidney Disease After Liver Transplantation (2010) (68)
- Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial. (2010) (66)
- Survival and Risk of Recidivism in Methadone‐Dependent Patients Undergoing Liver Transplantation (2003) (64)
- Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection. (2001) (64)
- Pegylated interferon–induced immune‐mediated hepatitis post–liver transplantation (2006) (62)
- Complicated hernia presentation in patients with advanced cirrhosis and refractory ascites: management and outcome. (2010) (62)
- Influenza Vaccination in Orthotopic Liver Transplant Recipients: Absence of Post Administration ALT Elevation (2004) (62)
- Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter (1996) (59)
- Hepatotoxicity and complementary and alternative medicines. (2003) (58)
- Liver transplantation for alcoholic hepatitis: A survey of liver transplant centers (2015) (57)
- A single nucleotide polymorphism of Toll-like receptor 4 identifies the risk of developing graft failure after liver transplantation. (2010) (57)
- An integrated approach to intestinal failure: Results of a new program with total parenteral nutrition, bowel rehabilitation, and transplantation (2002) (57)
- High-resolution endoluminal sonography is a sensitive modality for the identification of Barrett's metaplasia. (1997) (57)
- Use of high-resolution endoscopic ultrasonography to assess esophageal wall damage after pneumatic dilation and botulinum toxin injection to treat achalasia. (1996) (55)
- Efficacy of water-soluble vitamin E in the treatment of vitamin E malabsorption in short-bowel syndrome. (1994) (55)
- Chronic Hepatitis with Combined Features of Autoimmune Chronic Hepatitis and Chronic Hepatitis C: Favorable Response to Prednisone and Azathioprine (1995) (53)
- Tumors With Intrahepatic Bile Duct Differentiation in Cirrhosis: Implications on Outcomes After Liver Transplantation (2015) (53)
- Liver Failure and Need for Liver Transplantation in Patients With Advanced Hepatoportal Sclerosis (2007) (52)
- Outcome of COVID‐19 in Patients With Autoimmune Hepatitis: An International Multicenter Study (2021) (52)
- Prospective comparison of magnetic resonance imaging to transient elastography and serum markers for liver fibrosis detection (2016) (52)
- Chronic Ductopenic Rejection in Patients With Recurrent Hepatitis C Virus Treated With Pegylated Interferon Alfa-2a and Ribavirin (2007) (51)
- Clinical characterization of patients developing histologically‐proven fibrosing cholestatic hepatitis C post‐liver transplantation (2011) (50)
- Recurrent hepatitis C after retransplantation: Factors affecting graft and patient outcome (2005) (49)
- Sofosbuvir plus ledispasvir for recurrent hepatitis C in liver transplant recipients (2016) (49)
- Liver and Skin Histopathology in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease Type B) (2012) (49)
- Regression of hepatic fibrosis after intestinal transplantation in total parenteral nutrition liver disease. (2008) (48)
- Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. (2002) (48)
- Comparison of high‐resolution endoluminal sonography to video endoscopy in the detection and evaluation of esophageal varices (1996) (47)
- Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors (2005) (47)
- Use of high-resolution endoluminal sonography to measure the radius and wall thickness of esophageal varices. (1996) (46)
- The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis. (2020) (45)
- Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann–Pick disease type B (acid sphingomyelinase deficiency) (2015) (45)
- Underreporting of Liver Transplant Waitlist Removals Due to Death or Clinical Deterioration: Results at Four Major Centers (2013) (45)
- Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review. (2016) (43)
- The Impact of Polymorphisms in Chemokine and Chemokine Receptors on Outcomes in Liver Transplantation (2002) (43)
- Plasma cell hepatitis in hepatitis C virus patients post–liver transplantation: Case‐control study showing poor outcome and predictive features in the liver explant (2009) (43)
- Neoplastic seeding as a complication of percutaneous endoscopic gastrostomy. (1994) (43)
- Costs of telaprevir‐based triple therapy for hepatitis C: $189,000 per sustained virological response (2014) (42)
- The Impact of Costimulatory Molecule Gene Polymorphisms on Clinical Outcomes in Liver Transplantation (2003) (42)
- Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature. (2011) (41)
- Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirin. (2000) (40)
- High-resolution endoluminal sonography assessment of the hematocystic spots of esophageal varices. (1999) (39)
- Transplant Tourism in China: A Tale of Two Transplants (2010) (39)
- Fulminant hepatic failure secondary to malignant melanoma: case report and review of the literature (1999) (39)
- Hair Analysis Versus Conventional Methods of Drug Testing in Substance Abusers Seeking Organ Transplantation (2010) (38)
- Marked Differences in Acute Cellular Rejection Rates between Living-Donor and Deceased-Donor Liver Transplant Recipients (2005) (37)
- Fontan-Associated Liver Disease (2017) (36)
- Reversal of apparent AIDS dementia complex following treatment with vitamin B12 (1993) (35)
- Accurate method for clinical assessment of right lobe liver weight in adult living-related liver transplant. (2004) (35)
- Multivisceral transplantation for portal hypertension and diffuse mesenteric thrombosis caused by protein C deficiency (2002) (35)
- Recurrent hepatic sarcoidosis post‐liver transplantation manifesting with severe hypercalcemia: A case report and review of the literature (2005) (34)
- Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation (2012) (34)
- Obliterative Portal Venopathy: A Clinical and Histopathological Review (2013) (34)
- Decreased intrinsic factor secretion in AIDS: relation to parietal cell acid secretory capacity and vitamin B12 malabsorption. (1992) (34)
- High-resolution endoluminal sonography in achalasia. (1995) (32)
- Lysosomal acid lipase deficiency allograft recurrence and liver failure- clinical outcomes of 18 liver transplantation patients. (2018) (32)
- The burden of chronic kidney disease in long-term liver transplant recipients. (2008) (31)
- Liver Injury in Hospitalized Patients with COVID-19 Correlates with Hyper Inflammatory Response and Elevated IL-6. (2020) (30)
- Treatment Options for Hepatic Encephalopathy (2010) (30)
- Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation. (2012) (30)
- Successful combined liver-heart transplantation in adults: report of three patients and review of the literature. (1999) (30)
- Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis. (2019) (29)
- The beneficial impact of temporary porto‐caval shunt in orthotopic liver transplantation: a single center analysis (2011) (29)
- Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults. (2018) (29)
- Hepatocellular carcinoma in type 1 Gaucher disease: a case report with review of the literature. (2005) (29)
- Pretransplant Immunomodulation of Highly Sensitized Small Bowel Transplant Candidates with Intravenous Immune Globulin (2006) (29)
- Should living donor liver transplantation be an option when deceased donation is not? (2017) (28)
- The incidence and significance of late acute cellular rejection (>1000 days) after liver transplantation 1 (2004) (28)
- Noninvasive prediction of portal pressure with MR elastography and DCE‐MRI of the liver and spleen: Preliminary results (2018) (28)
- Rapid Reversal of Parenteral-Nutrition-Associated Cirrhosis Following Isolated Intestinal Transplantation (2009) (28)
- TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts. (2015) (27)
- Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis (2014) (27)
- Increasing hepatic arteriole wall thickness and decreased luminal diameter occur with increasing age in normal livers. (2011) (27)
- Geographic disparity: the dilemma of lower socioeconomic status, multiple listing, and death on the liver transplant waiting list (2014) (27)
- Results of steroid-based therapy for the hepatitis C–autoimmune hepatitis overlap syndrome (2001) (26)
- Surgery in patients with portal hypertension: a preoperative checklist and strategies for attenuating risk. (2014) (26)
- Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades (2019) (26)
- Imaging implications in the evaluation of permanent needle acupuncture. (1993) (26)
- LIVER INJURY FROM HERBS AND OTHER BOTANICALS (1998) (25)
- Use of Botulinum Toxin in the Treatment of Achalasia (1998) (25)
- The role of anticoagulation in pylephlebitis: a retrospective examination of characteristics and outcomes (2019) (25)
- Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus (2017) (25)
- Real-World Sustained Virologic Response Rates of Sofosbuvir-Containing Regimens in Patients Coinfected With Hepatitis C and HIV. (2016) (25)
- Prevention of the Osmotic Demyelination Syndrome After Liver Transplantation: A Multidisciplinary Perspective (2017) (25)
- Syngeneic living-donor liver transplantation without the use of immunosuppression. (2002) (25)
- The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV (2011) (24)
- Discovery and validation of a novel blood‐based molecular biomarker of rejection following liver transplantation (2020) (24)
- Right hepatectomy for living donation: role of remnant liver volume in predicting hepatic dysfunction and complications. (2013) (24)
- Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome (2020) (24)
- Hereditary hemochromatosis in liver transplantation. (1999) (23)
- Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis (2018) (23)
- Early and Frequent Histological Recurrence of Crohn's Disease in Small Intestinal Allografts (2005) (23)
- Immune‐mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct‐acting antiviral therapy (2018) (23)
- Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV–HIV Coinfected Liver Transplant Recipients (2014) (23)
- Findings of Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection (2020) (23)
- Long-term efficacy of olipudase alfa in adults with acid sphingomyelinase deficiency (ASMD): Further clearance of hepatic sphingomyelin is associated with additional improvements in pro- and anti-atherogenic lipid profiles after 42 months of treatment. (2019) (22)
- The dilemma and reality of transplant tourism: An ethical perspective for liver transplant programs (2010) (22)
- Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome (2022) (22)
- 28 EMTRICITABINE/TENOFOVIR DF COMBINATION +/− HBIG POST-ORTHOTOPIC LIVER TRANSPLANTATION TO PREVENT HEPATITIS B RECURRENCE IN PATIENTS WITH NORMAL TO MODERATE RENAL IMPAIRMENT: INTERIM RESULTS (2010) (22)
- The Complement System and C1q in Chronic Hepatitis C Virus Infection and Mixed Cryoglobulinemia (2018) (22)
- Peginterferon-&agr;-2b and Ribavirin for Hepatitis C Recurrence Postorthotopic Liver Transplantation (2012) (22)
- Adult presentation of Caroli's syndrome treated with orthotopic liver transplantation. (1997) (22)
- The Management of Hospitalized Patients with Cirrhosis: The Mount Sinai Experience and a Guide for Hospitalists (2011) (22)
- Analysis of Gene Polymorphisms in the Regulatory Region of MCP-1, RANTES, and CCR5 in Liver Transplant Recipients (2002) (21)
- ACE Gene D/D Genotype as a Risk Factor for Chronic Nephrotoxicity from Calcineurin Inhibitors in Liver Transplant Recipients (2006) (21)
- Outcomes of liver transplantation for acute fatty liver disease of pregnancy (2019) (21)
- Hepatocellular proliferation and changes in microarchitecture of right lobe allografts in adult transplant recipients (2004) (20)
- Comparative Killing Kinetics of Methicillin-Resistant Staphylococcus aureus by Bacitracin or Mupirocin (1996) (20)
- Subfulminant Liver Failure and Severe Hepatotoxicity Caused by Loratadine Use (1996) (20)
- Fatal fungemia resulting from an infected transjugular intrahepatic portosystemic shunt stent. (1997) (20)
- COVID‐19 Aftershocks on Alcohol‐Associated Liver Disease: An Early Cross‐Sectional Report From the U.S. Epicenter (2021) (20)
- Donor liver uridine diphosphate (UDP)-glucuronosyltransferase-1A1 deficiency causing Gilbert's syndrome in liver transplant recipients. (2000) (19)
- Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir (2014) (19)
- Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis (2021) (19)
- Long-term care of the liver transplant recipient. (2007) (19)
- Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation (2008) (18)
- Therapeutic management of recurrent hepatitis C after liver transplantation (2007) (18)
- Curricular guidelines for training in transplant hepatology (2002) (18)
- Mucosal Addressin Cell Adhesion Molecule (MAdCAM-1) Expression Is Upregulated in the Cirrhotic Liver and Immunolocalises to the Peribiliary Plexus and Lymphoid Aggregates (2013) (18)
- Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study (2009) (18)
- Thiamine status in patients receiving long-term home parenteral nutrition. (1996) (18)
- The pharmacokinetics and extracorporeal removal of N-acetylcysteine during renal replacement therapies (2015) (18)
- An Escalating Dose Regimen of Pegylated Interferon and Ribavirin in HCV Cirrhotic Patients Referred for Liver Transplant (2009) (18)
- Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis (2020) (18)
- Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced hepatocellular carcinoma (1998) (17)
- Rapidly progressive recurrent hepatitis C virus infection starting 9 days after liver transplantation (2007) (17)
- Long-term outcome after liver transplantation. (2012) (17)
- Acute Cellular Rejection Resulting in Sinusoidal Obstruction Syndrome and Ascites Postliver Transplantation (2011) (17)
- Medication adherence and rejection rates in older vs younger adult liver transplant recipients (2017) (17)
- Nevirapine‐Induced Stevens Johnson–Syndrome and Fulminant Hepatic Failure Requiring Liver Transplantation (2010) (16)
- Transplant tourism (2010) (16)
- Diagnosis of 6 Mercaptopurine Hepatotoxicity Post Liver Transplantation Utilizing Metabolite Assays (2004) (16)
- Overdose with suicidal intent: Ethical considerations for liver transplant programs (2011) (16)
- Non-invasive prediction of portal pressures using CT and MRI in chronic liver disease (2015) (16)
- Clearance of Hepatic Sphingomyelin by Olipudase Alfa Is Associated With Improvement in Lipid Profiles in Acid Sphingomyelinase Deficiency (2016) (16)
- Histological assessment of the liver explant in transplanted hepatitis C virus patients achieving sustained virological response with direct‐acting antiviral agents (2018) (16)
- Factors associated with persistent thrombocytopenia after liver transplantation. (2010) (16)
- Liver, simultaneous liver‐kidney, and kidney transplantation from hepatitis C‐positive donors in hepatitis C‐negative recipients: A single‐center study (2019) (16)
- Histopathology and clinical correlates of end‐stage hepatitis B cirrhosis: A possible mechanism to explain the response to antiviral therapy (2005) (16)
- Hepatocellular carcinoma associated with an atypical presentation of Wilson's disease. (2007) (16)
- Pretransplant Psychosocial Risk Factors May Not Predict Late Nonadherence and Graft Rejection in Adult Liver Transplant Recipients. (2017) (15)
- Use of splenic artery embolization to relieve tense ascites following liver transplantation in a patient with paroxysmal nocturnal hemoglobinuria (2007) (15)
- Liver transplantation is possible in some patients with liver metastasis of colon cancer. (2011) (15)
- Recurring fibro-obliterative venopathy in liver allografts. (1999) (15)
- Treating chronic hepatitis C in the primary care setting. (2005) (15)
- Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study (2017) (15)
- The Association of IL28B Polymorphism and Graft Survival in Patients with Hepatitis C Undergoing Liver Transplantation (2013) (15)
- Orthotopic liver transplantation for adults with Alagille syndrome (2012) (14)
- 640 HCV alternate reading frame proteins (ARFPS) may be virulence factors that help the virus survive adverse conditions (2003) (14)
- Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C (2013) (14)
- De Novo Hepatocellular Carcinoma Occurring in a Transplanted Liver: Case Report and Review of the Literature (2006) (14)
- A comparative study of portal vein embolization versus radiation lobectomy with Yttrium-90 micropheres in preparation for liver resection for initially unresectable hepatocellular carcinoma. (2021) (14)
- HIV infection modulates IL‐1β response to LPS stimulation through a TLR4‐NLRP3 pathway in human liver macrophages (2019) (14)
- Liver Injury in Patients Hospitalized with Coronavirus Disease 2019 Correlates with Hyperinflammatory Response and Elevated Interleukin‐6 (2020) (14)
- A Real-World Evaluation of Repeat Paracentesis-guided Management of Spontaneous Bacterial Peritonitis (2016) (13)
- Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn's disease. (2013) (13)
- A pleasant dilemma to have: to treat the HCV patient on the waiting list or to treat post‐liver transplantation? (2015) (13)
- Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis. (1997) (13)
- Acute Liver Failure Secondary to Drug-Induced Liver Injury. (2020) (13)
- Findings of Severe Hepatic SARS-CoV-2 Infection (2020) (13)
- Severe acute cellular rejection after intestinal transplantation is associated with poor patient and graft survival (2017) (13)
- Noninvasive imaging assessment of portal hypertension (2020) (13)
- Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis. (2020) (12)
- Severe but reversible hepatitis induced by troglitazone. (2000) (12)
- Hepatitis C virus double‐stranded RNA is the predominant form in human liver and in interferon‐treated cells (2016) (12)
- Waitlisted Candidates With Polycystic Liver Disease Are More Likely to be Transplanted Than Those With Chronic Liver Failure (2017) (12)
- Improved results in small bowel transplantation using sirolimus. (2002) (12)
- A review of the use of transient elastography in the assessment of fibrosis and steatosis in the post–liver transplant patient (2019) (12)
- Outcome of combined liver and kidney transplantation in hepatitis C: a single-center long-term follow-up experience. (2009) (12)
- Achalasia in a Patient with Gastroesophageal Varices: Problematic Treatment Decisions (2006) (12)
- Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome. (2001) (12)
- Idiopathic noncirrhotic portal hypertension. (2019) (11)
- In vivo comparison of esophageal varices at and above the diaphragmatic high pressure zone using high resolution endoluminal sonography. (1998) (11)
- Case Report: Severe but Reversible Hepatitis Induced by Troglitazone (2000) (11)
- Quantification of hepatic blood flow using a high-resolution phase-contrast MRI sequence with compressed sensing acceleration. (2015) (11)
- Effect of ischemia-reperfusion on the incidence of acute cellular rejection and timing of histologic hepatitis C virus recurrence after liver transplantation. (2008) (11)
- Isolated intestinal transplantation in adults with nonreconstructible GI tracts. (2000) (11)
- Alpha1-antichymotrypsin globules within hepatocytes in patients with chronic hepatitis C and cirrhosis. (2000) (11)
- A Physician's Guide to Nutrition in Chronic Disease Management for Older Adults (2003) (11)
- Complement component C3 allotypes and outcomes in liver transplantation (2010) (11)
- Clinical factors that predict noncirrhotic portal hypertension in HIV-infected patients: a proposed diagnostic algorithm. (2014) (11)
- The impact of donor liver allograft fibrosis on patients undergoing liver transplantation (2018) (11)
- Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience (2019) (10)
- The utility of thrombophilia testing in patients with newly diagnosed portal vein thrombosis. (2020) (10)
- Modern management of splenomegaly in patients with myelofibrosis (2020) (10)
- Safety of direct‐acting oral anticoagulants relative to warfarin in a matched cohort of liver transplant recipients (2019) (10)
- Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulation (2020) (10)
- Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation. (2022) (10)
- Absence of hepatitis G virus within liver tissue of patients undergoing liver transplantation for cryptogenic cirrhosis. (1999) (10)
- Successful use of tacrolimus for initial rejection episodes after liver transplantation. (1998) (10)
- Increased hepatic progenitor cell response and ductular reaction in patients with severe recurrent HCV post‐liver transplantation (2016) (10)
- Management of HCV Infection and Liver Transplantation (2006) (10)
- Individual liver plasmacytoid dendritic cells are capable of producing IFNα and multiple additional cytokines during chronic HCV infection (2019) (10)
- Excellent results of cardiac surgery in patients with previous liver transplantation (2007) (10)
- Standardized measures of frailty predict hospital length of stay following orthotopic liver transplantation for hepatocellular carcinoma (2019) (9)
- The Utility of Assessing Liver Allograft Fibrosis and Steatosis Post-Liver Transplantation Using Transient Elastography With Controlled Attenuation Parameter. (2020) (9)
- High‐risk liver transplant candidates: An ethical proposal on where to draw the line (2015) (9)
- Clinical Management of Hepatic Encephalopathy (2010) (9)
- Prevention of allograft HCV recurrence with peri‐transplant human monoclonal antibody MBL‐HCV1 combined with a single oral direct‐acting antiviral: A proof‐of‐concept study (2017) (9)
- The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel Disease. (2020) (9)
- Images in clinical medicine: acupuncture-needle fragments. (1995) (9)
- Discovery and Validation of a Biomarker Model (PRESERVE) Predictive of Renal Outcomes After Liver Transplantation (2020) (9)
- Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation (2020) (9)
- Comparsion of Hepatitis C Histological Recurrence Rates and Patient Survival Between Split and Deceased Donor Liver Transplantation (2007) (9)
- Still disease and the liver-an underappreciated association. (2011) (8)
- Adult live donor liver transplantation. (2005) (8)
- Possible Transmission of Hepatitis C Virus Infection with Intravenous Immunoglobulin (1995) (8)
- Kinetic patterns of liver enzyme elevation with COVID-19 in the USA (2020) (8)
- Steatohepatitic Variant of Hepatocellular Carcinoma Is Associated With Both Alcoholic Steatohepatitis and Nonalcoholic Steatohepatitis (2020) (8)
- The high incidence of severe chronic kidney disease after intestinal transplantation and its impact on patient and graft survival (2017) (8)
- Direct‐Acting Antiviral Treatment of Patients with Hepatitis C Resolves Serologic and Histopathologic Features of Autoimmune Hepatitis (2019) (8)
- Prevalence, Evolution, and Risk Factors for Advanced Liver Fibrosis in Adults Undergoing Intestinal Transplantation (2018) (8)
- Domino liver transplantation: a practical option in the face of the organ shortage. (2003) (8)
- Recurrence of Acute Intermittent Porphyria After Liver Transplantation (2019) (8)
- Segment 4 and the left lateral segment regeneration pattern after resection of the middle hepatic vein in a living donor right hepatectomy. (2015) (8)
- Genetic, hematological, and immunological disorders transmissible with liver transplantation (2017) (8)
- Routine surveillance endoscopy and biopsy after isolated intestinal transplantation—Revisiting the gold standard (2019) (8)
- Splenic T1ρ as a noninvasive biomarker for portal hypertension. (2020) (8)
- Lamivudine resistance leading to de novo hepatitis B infection in recipients of hepatitis B core antibody positive liver allografts (2014) (8)
- To B(iopsy) or not to B(iopsy) …. (2011) (8)
- Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still’s disease (2011) (8)
- Night blindness secondary to vitamin A deficiency in a patient with bile duct strictures after liver transplantation. (1998) (8)
- Case Report: Recognition of Nonhepatic Coma in the Setting of Acetaminophen Overdose (2004) (7)
- Hepatoportal sclerosis (obliterative portal venopathy) and nodular regenerative hyperplasia in a patient with myasthenia gravis: A case report and review of the published work (2013) (7)
- Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir‐based triple therapy (2014) (7)
- 795 REAL WORLD COSTS OF TELAPREVIR-BASED TRIPLE THERAPY, INCLUDING COSTS OF MANAGING ADVERSE EVENTS, AT THE MOUNT SINAI MEDICAL CENTER, NY: $147,000 PER EOT (2013) (7)
- Primary sclerosing cholangitis: detailed histologic assessment and integration using bioinformatics highlights arterial fibrointimal hyperplasia as a novel feature. (2015) (7)
- Human Peritoneal Macrophages From Ascitic Fluid Can be Infected by a Broad Range of HIV-1 Isolates (2010) (7)
- Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation. (2007) (7)
- Abstracts of the 25th Annual Conference of APASL, February 20–24, 2016, Tokyo, Japan (2016) (7)
- Antibody-mediated rejection of the liver allograft: an update and a clinico-pathological perspective. (2021) (7)
- A subset of liver resident natural killer cells is expanded in hepatitis C-infected patients with better liver function (2021) (7)
- The use of high frequency endoscopic ultrasonography probes in the evaluation of achalasia. (1995) (7)
- Extensive Health Care Utilization and Costs of an Early Liver Transplantation Program for Alcoholic Hepatitis (2021) (7)
- Hemophagocytic lymphohistiocytosis occurring after liver transplantation: A case series and review of the literature (2021) (6)
- Neurological Monitoring in Acute Liver Failure (2019) (6)
- Intestinal and multiorgan transplantation: the Mount Sinai experience. (2002) (6)
- Vitamin D status of human immunodeficiency virus–positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: Multi‐site study (2014) (6)
- Pneumatosis intestinalis and mesenteric venous gas - a manifestation of bacterascites in a patient with cirrhosis. (2011) (6)
- The presence of JAK 2 V 617 F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome (2009) (6)
- : drug hepatotoxicity (2007) (6)
- The Utility of a Pre-Transplant Psychosocial Evaluation in Predicting Post-Liver Transplant Outcomes (2020) (6)
- Pre‐liver transplant renal dysfunction and association with post‐transplant end‐stage renal disease: A single‐center examination of updated UNOS recommendations (2018) (6)
- Hepatotoxicity of Herbal Medicines, Vitamins and Natural Hepatotoxins (2007) (6)
- Exploring opportunities to prevent cirrhosis admissions in the emergency department: A multicenter multidisciplinary survey (2018) (6)
- Reassessing the safety concerns of utilizing blood donations from patients with hemochromatosis (2017) (6)
- Identification of ultrastructural changes in liver allografts of patients experiencing primary nonfunction. (2005) (5)
- Correlation Between Increased Colloid Osmotic Pressure and the Resolution of Refractory Ascites After Transjugular Intrahepatic Portosystemic Shunt (2000) (5)
- Exacerbation of Sickle Cell Disease Itself as a Cause of Abnormal Liver Chemistry Tests (2006) (5)
- Image segmentation of liver fibrosis (2008) (5)
- LP17 : Novel approach for the prevention of recurrent hepatitis C in liver transplant recipients: Preliminary results from ongoing phase III trial with civacir® (2015) (5)
- Development of a novel histologic diagnostic algorithm for hepatic graft-versus-host disease (2018) (5)
- Is Cholecystostomy a Safe Procedure in Patients with Cirrhosis? (2012) (5)
- Graft rejection occurring in post–liver transplant patients receiving cytotoxic chemotherapy: A case series (2009) (5)
- Comparative incidence of rejection occurring in small intestinal and colonic mucosal biopsies of patients undergoing intestinal transplantation (2016) (5)
- High baseline bilirubin and low albumin predict liver decompensation and serious adverse events in HCV‐infected patients treated with sofosbuvir‐containing regimens (2016) (5)
- Noninvasive diagnosis of portal hypertension using gadoxetate DCE-MRI of the liver and spleen (2021) (5)
- Evaluation and Management of Cirrhotic Patients Undergoing Elective Surgery (2019) (5)
- Hepatic artery aneurysm associated with acute gastroenteritis: successful treatment after intraperitoneal rupture. (1994) (5)
- An Association of Myeloproliferative Neoplasms and Obliterative Portal Venopathy (2014) (5)
- Telaprevir-induced DRESS. (2012) (5)
- MR elastography outperforms shear wave elastography for the diagnosis of clinically significant portal hypertension (2022) (5)
- Serum and Ascites Chromogranin-A in Patients With Metastatic Neuroendocrine Tumors (2011) (5)
- At Diagnosis of Hepatocellular Carcinoma, African Americans With Hepatitis C Have Better Liver Function Than Other Patients (2018) (5)
- Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection (2017) (4)
- A phase 1 trial of recombinant human acid Sphingomyelinase (rhASM) Enzyme replacement therapy in adults with Non-Neuronopathic ASM deficiency (ASMD Niemann-Pick B) (2011) (4)
- Direct‐acting antiviral regimens are safe and effective in the treatment of hepatitis C in simultaneous liver–kidney transplant recipients (2018) (4)
- 574 INTERIM 48 WEEK RESULTS OF A RANDOMIZED TRIAL OF EMTRICITABINE/TENOFOVIR DF PLUS/MINUS HBIG WITHDRAWAL IN POST-ORTHOTOPIC LIVER TRANSPLANT RECIPIENTS FOR CHRONIC HEPATITIS B (2011) (4)
- Recurrent Idiopathic Liver Allograft Failure. (2019) (4)
- Restoration of distorted colour microscopic images from transverse chromatic aberration of imperfect lenses (2011) (4)
- Index Use of Smoflipid in a Tertiary Intestinal Rehabilitation and Transplantation Program. (2017) (4)
- A morphometric study of the hepatic arterioles in end-stage primary sclerosing cholangitis (2015) (4)
- Comparison of outcome in patients with versus without ascites referred for either cardiac transplantation or ventricular assist device placement. (2015) (4)
- Chapter 8 – Drug-induced and toxic liver disease (2004) (4)
- Inpatient Specialty-Level Palliative Care is Delivered Late in the Course of Hepatocellular Carcinoma and Associated with Lower Hazard of Hospital Readmission. (2020) (4)
- Portal hypertension and hepatopulmonary syndrome in a middle-aged man with hepatitis B infection. (2000) (4)
- Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis. (2021) (4)
- Resolution of HCV-Autoimmune Hepatitis Overlap Syndrome With Antiviral TreatmentA Paired Liver Biopsy Study. (2019) (4)
- 1137 EFFECTIVENESS OF HCV TRIPLE THERAPY WITH TELAPREVIR IN NEW YORK CITY (2012) (4)
- The Future of Healing: Exploring the Parallels of Eastern and Western Medicine (2002) (4)
- Splanchnic vein thrombosis associated with myeloproliferative neoplasms. (2022) (4)
- The Implications of Liver Biopsy Results in Patients with Myeloproliferative Neoplasms Being Treated with Ruxolitinib (2019) (4)
- Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus. (2016) (4)
- Choice of Allograft in Patients Requiring Intestinal Transplantation: A Critical Review (2017) (4)
- Promoting Research with Organ Transplant Patients. (2018) (4)
- The Ethics of living related liver transplantation when deceased donation is not an option (2015) (4)
- Improving Advance Care Planning in Outpatients with Decompensated Cirrhosis: A Pilot Study: Advance Care Planning in Patients with Decompensated Cirrhosis. (2019) (4)
- 23 PEGINTERFERON ALFA-2B AND RIBAVIRIN FOR HEPATITIS C RECURRENCE POST ORTHOTOPIC LIVER TRANSPLANTATION (OLT): FINAL RESULTS FROM THE PROTECT STUDY (2010) (4)
- A woman with chronic anemia and cholestatic liver disease (2009) (3)
- Segmentation of textured cell images based on frequency analysis (2011) (3)
- Neutropenia induced by low-dose captopril. (1992) (3)
- Outcomes of spontaneous bacterial peritonitis in liver transplant recipients with allograft failure (2016) (3)
- Hepatocellular Carcinoma: A Wrinkle in the Emerging Palliative Care/Oncology Paradigm. (2017) (3)
- Characteristics, anticoagulation, and outcomes of portal vein thrombosis after intra-abdominal surgery. (2020) (3)
- Jaundice developing in a patient with hepatitis C 4 months after liver transplantation (2009) (3)
- Justice in Transplant Organ Allocation (2012) (3)
- The dynamic and clinical significance of autoantibodies and immunoglobulins in liver transplant recipients (2016) (3)
- Blue nasal secretions: A presentation of Gaucher's disease and concurrent hemosiderosis (1993) (3)
- Efficacy and safety of mammalian target of rapamycin inhibitors following intestinal and multivisceral transplantation (2021) (3)
- Primary intestinal autoimmune disease as a cause of chronic intestinal pseudo-obstruction (2005) (3)
- The role of endoscopy in the small intestinal transplant recipient: A review (2020) (3)
- Endoscopic Diagnosis of Bleeding Meckel's Diverticulum in a Multivisceral Transplant Recipient (2003) (3)
- Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C−positive Donors in the United States: An Analysis of the OPTN/UNOS Database (2022) (3)
- Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol‐associated hepatitis (2022) (3)
- Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results (2017) (3)
- MRI is the most commonly used imaging modality for HCC screening at a tertiary care transplant center (2021) (3)
- The Impact of Cirrhosis and Prescription Medications on QTc Interval Before and After Liver Transplantation (2019) (3)
- Aberrant von Willebrand factor expression of sinusoidal endothelial cells and quiescence of hepatic stellate cells in nodular regenerative hyperplasia and obliterative portal venopathy (2020) (3)
- The clinical characteristics, pre‐ and post–liver transplantation outcomes in patients having autoimmune overlap syndromes (2020) (2)
- Hypo‐vascular hepatocellular carcinoma and liver transplantation: Morphological characteristics and implications on outcomes (2019) (2)
- An active esophageal prosthesis. (1995) (2)
- FACTORS ASSOCIATED WITH RECURRENCE OF AUTOIMMUNE HEPATITIS AFTER LIVER TRANSPLANTATION AND EFFECTS ON GRAFT AND PATIENT SURVIVAL (2019) (2)
- Is there a better way to monitor abstinence among substance abusers awaiting transplantation? (2012) (2)
- Long-term follow-up of liver transplant recipients undergoing cyclosporine withdrawal. (2001) (2)
- An integrated approach to intestinal failure: Results of a new program with TPN, bowel rehabilitation and intestinal transplantation (2000) (2)
- Clinical characteristics of human immunodeficiency virus patients being referred for liver transplant evaluation: a descriptive cohort study (2015) (2)
- O110 : Simeprevir + sofosbuvir combination therapy for recurrent genotype-1 hepatitis C in liver transplant recipients : A real-life multicenter experience (2015) (2)
- Effects of Liver Disease on Drug Metabolism in Humans (2012) (2)
- Burnout Among Transplant Hepatologists in the United States (2021) (2)
- Moral Complexity and the Delusion of Moral Purity (2010) (2)
- A patient with no known liver disease presenting with a sentinel variceal hemorrhage (2009) (2)
- Evaluation of the fibrosis-4 index for detection of advanced fibrosis among individuals at risk for intestinal failure associated liver disease. (2021) (2)
- The anion gap in lactic acidosis (1994) (2)
- Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid. (2011) (2)
- Eliminating transplant tourism in the United States as a means to decrease wait‐list mortality of US residents (2015) (2)
- Lactulose: How Many Ways Can One Drug Be Prescribed? (2011) (2)
- MELD—good for many, not as good for others … at least for now (2013) (2)
- COVID‐19 Aftershocks on Alcohol‐Associated Liver Disease: An Early Cross‐Sectional Report From the U.S. Epicenter (2021) (2)
- Chapter 28 – Occupational and Environmental Hepatotoxicity (2006) (2)
- PATTERNS OF ALCOHOL USE AFTER EARLY LIVER TRANSPLANTATION (LT) FOR ALCOHOLIC HEPATITIS (AH): IMPLICATIONS FOR SELECTION AND MONITORING (2019) (1)
- Telaprevir activity in treatment-naive patients infected with hepatitis C virus genotype 4. (2014) (1)
- Histological Assessment of the Liver Explant in Transplanted HCV-Patients Achieving Sustained Virologic Response with Direct-Acting Antiviral Agents Running Title : Histologic assessment of HCV patients with SVR (2017) (1)
- Telaprevir, Pegylated Interferon Alfa-2a, and Ribavirin for Hepatitis C Virus Genotype 4 Infection (2014) (1)
- P0881 : Real world effectiveness and cost of simeprevir- and/or sofosbuvir-based HCV treatments: $175,000 per SVR12 (2015) (1)
- Outcomes of Splanchnic Vein Thrombosis in Patients with Myeloproliferative Neoplasms Treated with Direct Oral Anticoagulants (2019) (1)
- The Use of Direct Oral Anticoagulants in Non-Cirrhotic Portal Vein Thrombosis (2019) (1)
- Duck Bone Perforation of the small Bowel (1993) (1)
- Non-cirrhotic portal hypertension. (2014) (1)
- Corrigendum to "Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis" [J. Autoimmun. 119C (2021) 102629]. (2021) (1)
- P3B.17: Complex relation between timing of acute rejection, severity, and graft loss in isolated intestinal transplantation (2019) (1)
- A blinded controlled comparison of high resolution endoluminal sonography to video endoscopy in the detection and evaluation of esophageal varices (1995) (1)
- Acute cellular rejection and its sequelae developing in a 42‐year‐old man after liver transplantation (2009) (1)
- An analysis of the outcomes of Clostridioides difficile occurring in intestinal transplant recipients requiring hospitalization (2023) (1)
- Gallbladder perforation presenting as significant hyperbilirubinemia. (1992) (1)
- Fatal cerebral edema in patients with decompensated cirrhosis: A case series. (2020) (1)
- The utility of thrombophilia and hematologic screening in live liver donation (2020) (1)
- Identification and clinical significance of nodular regenerative hyperplasia in primary sclerosing cholangitis (2022) (1)
- Virologic Response of Antiviral Therapy in Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Liver Transplant (LT) Recipients: 1405 (2012) (1)
- P1161 PERI-TRANSPLANT TREATMENT WITH ANTI-HCV E2 HUMAN MONOCLONAL ANTIBODY MBL-HCV1 IN COMBINATION WITH A PROTEASE INHIBITOR RESULTS IN UNDETECTABLE HCVRNA IN THE EARLY POST-TRANSPLANT PERIOD (2014) (1)
- CTLA4 POLYMORPHISMS CONFER SUSCEPTIBILITY TO ACUTE ALLOGRAFT REJECTION.: Abstract# 1076 (2000) (1)
- A protocol for the management of hyponatremia peri‐liver transplant reduces post‐transplant neurological complications (2021) (1)
- A comparative study of cirrhosis sub-staging using the Laennec system, Beijing classification, and morphometry (2021) (1)
- Preoperative and Postoperative Care of the Liver Patient (2017) (1)
- Radiological and pathological assessment with EOB-MRI after Y90 radiation lobectomy prior to liver resection for hepatocellular carcinoma. (2022) (1)
- Sa1011 Noncirrhotic Portal Hypertension (NCPH) in HIV-Infected Patients: A Case Control Study (2012) (1)
- Epiploic Appendagitis After Liver Transplantation: Diagnosis and Management: 786 (2010) (1)
- Hepatitis C and Human Immunodeficiency Virus Kidney Transplantation: The Mount Sinai Experience. (2015) (1)
- Delayed diagnosis of cholestatic drug-induced liver injury treated with corticosteroid for adrenal insufficiency secondary to miliary tuberculosis. (2015) (1)
- Hepatic Progenitor Cells: Their Possible Role in Recurrent HCV and Allograft Loss Post-Liver Transplantation (2008) (0)
- Hepatitis C immune globulin (human) for the prevention of viral recurrence after liver transplantation (2007) (0)
- Disease severity scoring system for acid sphingomyelinase deficiency: Severity score domains and components (2018) (0)
- Domino Liver Transplantation: A Practical Option in the Face of the Organ Shortage (2003) (0)
- Liver Transplantation in Wilson Disease (2019) (0)
- Utility of Thrombophilia Testing in Portal Vein Thrombosis in a Large Single Institutional Cohort (2019) (0)
- Limited upper midline incision for major hepatectomy in adults: safety and feasibility. (2021) (0)
- Early neurologic complications post liver transplant are associated with reduced long-term survival and increased rates of rejection. (2023) (0)
- A new approach for treatment of hepatitis C in hepatitis C-autoimmune hepatitis overlap syndrome. (2010) (0)
- P2.55: Decreasing Tacrolimus Time-In-Therapeutic Range is Associated with an Increased Incidence and Severity of Rejection Following Intestinal Transplant (2019) (0)
- Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis. (2023) (0)
- Sustained Viral Response after Treatment with Ledipasvir/Sofosbuvir (Harvoni®) in a Patient with Hepatitis C Following Intestine and Renal Transplantation (2017) (0)
- PRO (“The Window Is Open”): In patients with cirrhosis with prior variceal hemorrhage and ascites, the clinical benefits of nonselective beta‐blockers outweigh the risks and should be prescribed (2018) (0)
- The utility and complications of plasma administration in cirrhotic patients undergoing minimally invasive procedures. (2021) (0)
- DONOR LIVER UDP-GLUCORONOSYLTRANSFERASE-1 DEFICIENCY CAUSING GILBERT'S SYNDROME IN LIVER TRANSPLANT RECIPIENTS. (1999) (0)
- ACCURACY AND USEFULNESS OF MR CHOLANGIOGRAPHY IN THE DIAGNOSIS AND MANAGEMENT OF POST‐TRANSPLANT BILIARY COMPLICATIONS.: Abstract# 1068 (2000) (0)
- Successful pathways to liver transplant for undocumented immigrants: the PRUCOL process. (2023) (0)
- Sa1376: BARRIERS AND FACILITATORS OF PALLIATIVE CARE REFERRAL FOR PEOPLE WITH HEPATOCELLULAR CARCINOMA: A QUALITATIVE STUDY OF CLINICIAN VIEWS (2022) (0)
- INTESTINAL TRANSPLANTATION WITH LYMPHOCYTOXIC CROSSMATCHING.: Abstract# 272 Poster Board #‐Session: P119‐I (2000) (0)
- ReviewDisease and the Liver (2011) (0)
- Improving Documentation of Advance Care Planning in Outpatients with Decompensated Cirrhosis (RP309) (2020) (0)
- Inpatient Palliative Care Consultation Is Associated with Lower Hazard of Readmission for Patients with Hepatocellular Carcinoma (RP506) (2020) (0)
- Outcomes of Anesthesiologist-Led Care of Patients Following Liver Transplantation During the COVID-19 Pandemic (2022) (0)
- Su1629 AN ANALYSIS OF THE UTILITY OF FFP ADMINISTRATION IN CIRRHOTIC PATIENTS UNDERGOING INVASIVE PROCEDURES (2020) (0)
- Increased thickness of abdominal subcutaneous adipose tissue occurs more frequently in steatohepatitis than in simple steatosis. (2013) (0)
- The presence of non‐hepatic malignancy and its implication in pursuing liver transplantation (2021) (0)
- 774 Interferon-based treatment for recurrent HCV infection does not influence the progression of hepatic fibrosis in liver transplant recipients (2003) (0)
- Fulminant Autoimmune Hepatitis Induced by Infliximab Therapy: a Rare Case Report (2008) (0)
- Use of high resolution endoluminal sonography to measure variables (wall thickness and radius) involved in the calculation of variceal wall tension by the laplace equation (1995) (0)
- Successful intestinal transplantation: Surgical and immunological considerations (2000) (0)
- 35.35: The utility of repeat stress SPECT myocardial perfusion imaging in patients with end stage liver disease (2008) (0)
- Sa1505 – Persistent Renal Dysfunction in the First Week of Hospital Admission is the Strongest Predictor of Transplant Free Survival in Patients with Severe Alcoholic Hepatitis (2019) (0)
- SIMULTANEOUS LIVER AND KIDNEY TRANSPLANTATION: THE LACK OF INFLUENCE OF PREFORMED DSA (2020) (0)
- P2.48: Safety and efficacy of mTOR inhibitors following intestine and multivisceral transplantation (2019) (0)
- T1650 Complicated Umbilical Hernias in Cirrhotic Patients With Refractory Ascites: Management and Outcome (2010) (0)
- Recurrent hepatitis C virus infection and outcome after living-donor liver transplant. (2013) (0)
- Re-Visiting Surgical Options for Diffuse Porto-Mesenteric Thrombosis in the Era of Multi-Visceral Transplantation – A Case for Aggressive Conservatism (2011) (0)
- Clinical problem-solving: trapped by an incidental finding. (1992) (0)
- DCD Hepatitis C Virus–positive Donor Livers Can Achieve Favorable Outcomes With Liver Transplantation and Are Underutilized (2022) (0)
- Endoscopic ultrasound is the best method to assess objective response to multimodal therapy for esophageal cancer (1995) (0)
- Temporal and geographical trends of intestinal transplantation in the USA. (2018) (0)
- Su1637 EVIDENCE OF PRIOR ADVANCE CARE PLANNING IS SPARSE AMONG OUTPATIENTS WITH DECOMPENSATED CIRRHOSIS (2020) (0)
- 831Clinical Characteristics and Outcomes in Patients with Hospital-Acquired, Healthcare-Associated and Community-Acquired Spontaneous Bacterial Peritonitis (2014) (0)
- Long-term efficacy of olipudase alfa in adults with acid sphingomyelinase deficiency (ASMD): Further clearance of hepatic sphingomyelin is associated with additional improvements in pro- and anti-atherogenic lipid profiles after 3.5 years of treatment (2019) (0)
- Outcomes after Liver Transplantation with Steatotic Grafts: Redefining Acceptable Cutoffs for Steatotic Grafts (2022) (0)
- Endoscopic retrieval of a concealed parcel (ERCP) (1996) (0)
- Outcomes of Abdominal Thrombosis in Patients with Myeloproliferative Neoplasms in a Single Center Experience (2018) (0)
- Long-term Effects of Bariatric Surgery in Patients with Non-alcoholic Fatty Liver Disease: A Literature Review and Meta-Analysis: 850 (2016) (0)
- 204 SAFETY, EFFICACY AND PREDICTORS OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT IN REFRACTORY HEPATIC HYDROTHORAX (2010) (0)
- Commentary: real‐world triple therapy experience treating hepatitis C virus – authors' reply (2014) (0)
- Prevalence and Risk Factors for Advanced Liver Fibrosis in Adults Undergoing Intestinal Transplantation (2017) (0)
- An adolescent presenting with hematemesis and renal abnormalities (2009) (0)
- Two hundred and fifty-one right hepatectomies for living donation: Association between preoperative risk factors, hepatic dysfunction, and complications. (2022) (0)
- The Effect of the COVID-19 Pandemic in Intestinal Rehabilitation and Transplant Patients: Initial Results of the Intestinal Rehabilitation and Transplant Association’s International Survey (2022) (0)
- Index Use of SMOF Lipid in a Quaternary Level Intestinal Rehabilitation and Transplantation Program (2017) (0)
- An Unusual Case of Noncirrhotic Portal Hypertension: Splenic Hemangiomatosis: 858 (2009) (0)
- Histologic and Clinical Outcomes of Patients Developing Post-Liver Transplant Plasma Cell-Rich Rejection. (2023) (0)
- The use of transient elastography in identifying sub-clinical chronic ductopenic rejection in adult liver transplant recipients: A case series. (2022) (0)
- Ethics and liver transplantation: A new section in our journal (2008) (0)
- 441 Primary non-function is associated with ultrastructural changes in the liver allograft (2003) (0)
- A clinical, laboratory, and pathologic characterization of patients with hepatic sarcoidosis (1998) (0)
- Prevalence of Micronutrient Deficiencies after Adult Intestinal Transplantation (2017) (0)
- Reply (2012) (0)
- 320.10: “Stoma or no stoma that is the question”: a single-center experience of intestinal transplantation without stoma (2019) (0)
- The Quantification and Significance of Extramedullary Hematopoiesis Seen on Liver Biopsy Specimens. (2022) (0)
- Orthotopic Liver Transplantion: Not the CURE for Caroliʼs Disease in All Cases (2008) (0)
- S1355 Sepsis in Hospitalizations With Short Bowel Syndrome: A 10-Year Analysis From the National Inpatient Sample Database (2021) (0)
- A Continuum of Histopathologic Disease is Present in Adults with Acid Sphingomyelinase Deficiency (Niemann-Pick Disease Type B) (2012) (0)
- Performance of native and gadoxetate-enhanced liver and spleen T1 mapping for noninvasive diagnosis of clinically significant portal hypertension: preliminary results (2022) (0)
- The JAK2V617F Mutation Is Present in the Liver Endothelial Cells of Patients with Budd-Chiari Syndrome (2008) (0)
- Ascites and variceal bleeding occurring in a 20‐year‐old with cystic fibrosis (2009) (0)
- Recurrent Liver Allograft Injury in Patients With Donor-Derived Malignancy Treated With Immunosuppression Cessation and Retransplantation. (2022) (0)
- A Review of the Clinical Presentation, Outcomes and Treatments of Patients Having Desmoid Tumors (2023) (0)
- Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus. (2015) (0)
- Mo1518 – Predictors of Mortality in Inter-Hospital Transfers to a Liver Transplant Center: A Study of 683 New Patients (2019) (0)
- Early Outcomes of a Stepwise Desensitization Strategy to Facilitate Intestinal Transplantation (2017) (0)
- Recurrent Disease Post‐Liver Transplantation: Autoimmune Diseases, Hepatitis B and NASH (2014) (0)
- A multicentric study to estimate mortality and graft loss risk after liver transplantation (LT) in patients with recurrent primary biliary cholangitis (PBC) (2022) (0)
- Hepatic pathology of acid sphingomyelinase deficiency: Clearance of sphingomyelin with recombinant human acid sphingomyelinase administration is associated with improvement in pro-atherogenic lipid profiles (2015) (0)
- An unusual case of congenital splenic cyst presenting as biliary colic. (1994) (0)
- Small-for-size Syndrome Does Not Occur in Intestinal Transplantation Without Liver Containing Grafts (2018) (0)
- O-22: The Effect of the COVID-19 Pandemic in Intestinal Rehabilitation and Transplant Patients, Initial Results of an International Survey (2021) (0)
- Quality of life after lobectomy for adult liver transplantation1 (2002) (0)
- P3A.07: Impact of Donor and Recipient CYP3A5 and ABCB1 Genotype on Tacrolimus Trough/Dose Ratios Following Intestinal Transplant (2019) (0)
- New developments in drug hepatotoxicity (1995) (0)
- Hepatitis C Post‐Liver Transplantation (2014) (0)
- The Importance of Segment 4 Anatomy on Outcomes Following Living Donor Left Lateral Segmentectomy. (2023) (0)
- Liver Disease During Pregnancy. (2022) (0)
- Treatment of hepatitis C in the potential liver transplant recipient (2009) (0)
- Sa1565 CHILD-TURCOTTE-PUGH CLASS AT TRANSPLANTATION PREDICTS POST-TRANSPLANTATION MORTALITY AMONG PATIENTS UNDERGOING HEART TRANSPLANTATION FOLLOWING LEFT VENTRICULAR ASSIST DEVICE PLACEMENT (2020) (0)
- Long-term outcome of patients undergoing OLT for hepatitis B-related liver disease without HBIG prophylaxia (1998) (0)
- Alcohol-associated hepatitis with acute-on-chronic liver failure in a diverse cohort: lung and circulatory organ failures along with MELD 35 are predictive of mortality (2022) (0)
- Rapidly progressive hepatosteatosis and liver failure five years after liver transplantation in a patient with lysosomal acid lipase deficiency (2017) (0)
- Mo1912 Changes in Autoimmune Markers Occurring in Liver Transplant Recipients (2012) (0)
- Regional and National Trends of Adult Living Donor Liver Transplantation in the United States Over the Last Two Decades (2022) (0)
- Recurrence of HCC When Transplanted Outside Milan Criteria (2016) (0)
- Congress of the International Intestinal Rehabilitation and Transplantation Association (CIRTA) Abstracts. (2017) (0)
- Sa1965 Hepatitis C Virus (HCV) Double-Stranded RNA is Abundant and May Be an Important Viral Reservoir in Persistence and Relapse (2012) (0)
- Outcomes of Treatment for Hepatic Sarcoidosis: A Literature Review and Meta-Analysis: 768 (2016) (0)
- Child‐Turcotte‐Pugh versus MELD‐XI identify distinct high‐risk populations for heart transplantation following ventricular assist device placement (2022) (0)
- Image Segmentation of Secondary Septa in Lungs (2011) (0)
- Current Clinical Practice. Diseases of the Liver and Bile Ducts. Diagnosis and treatment (1999) (0)
- 1027 Incidence of hepatitis C recurrence and survival after liver transplantation: split vs cadaveric liver transplantation (2003) (0)
- Does Small for Size Syndrome Occur in Intestinal Transplantation (2017) (0)
- 1367 NONCIRRHOTIC PORTAL HYPERTENSION (NCPH) IN HIV-INFECTED PATIENTS: A CASE CONTROL STUDY (2012) (0)
- RIGINAL ARTICLES — LIVER , PANCREAS , ND BILIARY TRACT actors That Predict Outcome of Abdominal Operations in Patients With dvanced Cirrhosis (0)
- Revisiting Need for Routine Surveillance Endoscopy after Intestinal Transplantation (2017) (0)
- The Efficacy of Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis: A Meta-Analysis and Systematic Review: 882 (2016) (0)
- Re-establishing abstinence after alcohol relapse after early transplant (LT) for alcoholic hepatitis (AH) provides survival advantage (2020) (0)
- Comment on "Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis". (2020) (0)
- Multidisciplinary Non-Transplant Management of Confluent Porto-Mesenteric Thrombosis (2017) (0)
- The influence of donor age on fibrosis progression rate in recurrent hepatitis C post-liver transplantation (2003) (0)
- Autoimmune Hepatitis Secondary to Infliximab in Inflammatory Bowel Disease: A Case Report and Review of Clinical Management: 956 (2011) (0)
- Systemic Disease and the Liver-Part 1: Systemic Lupus Erythematosus, Celiac Disease, Rheumatoid Arthritis and COVID-19 (2023) (0)
- 461: The Impact of Body Mass Index on Acute Liver Failure Patient Outcomes (2020) (0)
- The novel hepatitis C virus (HCV) alternate reading frame proteins (ARFPs) are over-expressed in patients with HCV cirrhosis and hepatocellular carcinoma (HCC) (2004) (0)
- Factors Associated With Failure Of Telaprevir- And Boceprevir-Based Hcv Triple Therapy (2014) (0)
- "Irony" of managing refractory anemia with transfusional support in hemophagocytic lymphohistiocytosis. (2016) (0)
- Hepatology Clearance for Immunomodulation in Patients With Hepatitis B (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Thomas D. Schiano?
Thomas D. Schiano is affiliated with the following schools:
